Health Policy and Advocacy

As the leading voice of independent urology group practices in the US, LUGPA educates policymakers on the benefits of integrated urologic care. Our members drive grassroots efforts by developing thoughtful analysis and engaging public officials on major legislative and regulatory proposals.


2019 Federal Legislative and Regulatory Priorities

Promote neutrality of physician reimbursement regardless of site of service.
LUGPA is focused ensuring that independent physician practices can complete with mega-hospitals and offer more efficient, high-quality care in patients’ communities. [Read more]

Maintain patient access to physician-administered cancer therapy through Medicare Part B.
LUGPA is committed to ensuring appropriate patient access to drugs and believes proposed changes should be considered and enacted by Congress. [Read more]

Promote Stark reform to allow independent practices to thrive under MACRA while maintaining the IOASE.
LUGPA supports enactment of legislation that would permit our practices to participate in Alternative Payment Models. In addition, LUGPA will continue to defend the In-Office Ancillary Service Exemption. [Read more]

Closely monitor CMS development of legislatively mandated radiation therapy bundles to ensure patient access to cancer treatment.
LUGPA will work with CMS to ensure that any proposed bundled payment for radiation services protects adequate patient access to care. [Read more]

Continue to monitor and provide comments to CMS regarding policies that affect Medicare fee schedules.
LUGPA will advocate for changes to the Medicare physician fee schedule that benefit our practices and urology patients. [Read more]

Monitor regulatory implementation of MACRA. LUGPA will encourage CMS to reward high performers in MIPS and approve more APMs in which our practices can participate. [Read more]

Advocate for physicians’ ability to continue to provide in-office dispensing of pharmaceuticals.
LUGPA is committed to protecting patients’ ability to receive pharmaceuticals from their physicians when they so choose and allowed by state statute. Physicians are highly attuned to their patients’ clinical needs and by integrating pharmaceutical dispensing into physician practices, care coordination is enhanced and patient compliance is better monitored. [Read more]

Promote reform of the USPSTF to allow for greater transparency and stakeholder engagement. LUGPA supports legislation to provide greater transparency and accountability of the USPSTF. Given the substantial decrease in the number of men identified with prostate cancer, increased transparency and consultation with stakeholders in USPSTF decision-making is essential. [Read more]